241 related articles for article (PubMed ID: 19779623)
1. Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells.
Vercoulen Y; Wehrens EJ; van Teijlingen NH; de Jager W; Beekman JM; Prakken BJ
PLoS One; 2009 Sep; 4(9):e7183. PubMed ID: 19779623
[TBL] [Abstract][Full Text] [Related]
2. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
Wang ZH; Zhu JY; Li T; Leng XS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
[TBL] [Abstract][Full Text] [Related]
3. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
Allan SE; Crome SQ; Crellin NK; Passerini L; Steiner TS; Bacchetta R; Roncarolo MG; Levings MK
Int Immunol; 2007 Apr; 19(4):345-54. PubMed ID: 17329235
[TBL] [Abstract][Full Text] [Related]
4. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
[TBL] [Abstract][Full Text] [Related]
6. Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells.
Haufe S; Haug M; Schepp C; Kuemmerle-Deschner J; Hansmann S; Rieber N; Tzaribachev N; Hospach T; Maier J; Dannecker GE; Holzer U
Arthritis Rheum; 2011 Oct; 63(10):3153-62. PubMed ID: 21702013
[TBL] [Abstract][Full Text] [Related]
7. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
[TBL] [Abstract][Full Text] [Related]
10. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
11. CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitis.
Götlind YY; Raghavan S; Bland PW; Hörnquist EH
PLoS One; 2011; 6(9):e25073. PubMed ID: 21966415
[TBL] [Abstract][Full Text] [Related]
12. IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.
Turka LA; Walsh PT
Front Biosci; 2008 Jan; 13():1440-6. PubMed ID: 17981641
[TBL] [Abstract][Full Text] [Related]
13. Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.
López-Abente J; Martínez-Bonet M; Bernaldo-de-Quirós E; Camino M; Gil N; Panadero E; Gil-Jaurena JM; Clemente M; Urschel S; West L; Pion M; Correa-Rocha R
Sci Rep; 2021 Jan; 11(1):827. PubMed ID: 33436905
[TBL] [Abstract][Full Text] [Related]
14. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
15. High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis.
Li J; Ridgway W; Fathman CG; Tse HY; Shaw MK
J Neuroimmunol; 2007 Dec; 192(1-2):57-67. PubMed ID: 17920698
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑21‑5p protects melanocytes via targeting STAT3 and modulating Treg/Teff balance to alleviate vitiligo.
Huo J; Liu T; Li F; Song X; Hou X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200798
[TBL] [Abstract][Full Text] [Related]
17. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
Cabrera R; Ararat M; Eksioglu EA; Cao M; Xu Y; Wasserfall C; Atkinson MA; Liu C; Nelson DR
Scand J Immunol; 2010 Oct; 72(4):293-301. PubMed ID: 20883314
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.
Wilhelm AJ; Rhoads JP; Wade NS; Major AS
Ann Rheum Dis; 2015 Apr; 74(4):778-85. PubMed ID: 24395554
[TBL] [Abstract][Full Text] [Related]
19. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
[TBL] [Abstract][Full Text] [Related]
20. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
Cabrera R; Ararat M; Xu Y; Brusko T; Wasserfall C; Atkinson MA; Chang LJ; Liu C; Nelson DR
Cancer Immunol Immunother; 2013 Apr; 62(4):737-46. PubMed ID: 23223899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
